OTCMKTS:ABAHF Abacus Health Products (ABAHF) Stock Price, News & Analysis $4.84 -0.26 (-5.10%) As of 06/11/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Abacus Health Products Stock (OTCMKTS:ABAHF) Get Abacus Health Products alerts:Sign Up Key Stats Today's Range$4.60▼$5.5050-Day Range$4.84▼$4.8452-Week Range$1.12▼$8.40Volume9,300 shsAverage Volume10,164 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers. Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms. Products are manufactured under contract with North American facilities that meet regulatory standards, and Abacus works closely with licensing partners to secure distribution rights. This approach allows the company to focus its internal resources on marketing, regulatory support and sales channel development. Headquartered in Canada, Abacus Health Products distributes its line-up across Canadian provinces and the United States, utilizing a combination of national pharmacy chains, independent drugstores and e-commerce platforms. The company’s commercial strategy is supported by a network of specialty sales representatives and digital marketing initiatives designed to educate healthcare professionals and consumers about product benefits. Abacus continues to explore new licensing and acquisition opportunities to expand its presence in selected niche markets.AI Generated. May Contain Errors. Read More Receive ABAHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abacus Health Products and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABAHF Stock News HeadlinesAbacus Life Provides Preliminary Third Quarter 2024 ResultsOctober 22, 2024 | markets.businessinsider.comTop 5 Best Products for Gut Health in 2024March 3, 2024 | benzinga.comTrump’s Dollar ResetPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December. | Porter & Company (Ad)Abacus Health Products, Inc.February 15, 2024 | thestreet.comOrchestral Tools Abacus reviewDecember 24, 2023 | yahoo.comUnited Health Products Inc UEECDecember 2, 2023 | morningstar.comMNYC Health and Hospitals-South Brooklyn HealthOctober 25, 2023 | health.usnews.com2 more eye drop products recalled after being linked to potentially deadly bacteriaSeptember 10, 2023 | usatoday.comSee More Headlines ABAHF Stock Analysis - Frequently Asked Questions How have ABAHF shares performed this year? Abacus Health Products' stock was trading at $4.84 at the beginning of the year. Since then, ABAHF shares have increased by 0.0% and is now trading at $4.84. How do I buy shares of Abacus Health Products? Shares of ABAHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:ABAHF CIKN/A Webabacushp.com PhoneN/AFaxN/AEmployees29Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:ABAHF) was last updated on 6/28/2026 by MarketBeat.com Staff. From Our PartnersSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredElon’s message for AmericaElon Musk bought Super Bowl ad time at $266,000 per second - something he has never done before. 125 million A...Stansberry Research | SponsoredAre we ignoring the same signal Wall Street ignored in 1929?In 1929, a 20-something broker named Irving Weiss shorted the market before Black Monday and made a fortune. H...Weiss Ratings | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredThe $700 billion problem Elon, Zuck, and Pichai can't fixElon Musk warned that AI will demand more electricity than the grid can supply. Morgan Stanley backs him up - ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abacus Health Products Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abacus Health Products With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.